Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs
Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m doses.
The US drugmaker Johnson & Johnson announced on Friday that its vaccine – which requires only one dose – is effective. This followed Thursday’s news that the Novavax vaccine, which will be manufactured in the UK, performed well in phase 3 trials.
